Puma Biotechnology (PBYI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 31,111 | 17,673 | 8,829 | 2,974 | 30,278 |
| Depreciation Amortization | 10,938 | 8,281 | 5,559 | 2,796 | 11,524 |
| Income taxes - deferred | 3,245 | N/A | N/A | N/A | -7,075 |
| Accounts receivable | -21,281 | -1,192 | 6,250 | 6,626 | 16,345 |
| Accounts payable and accrued liabilities | -453 | 877 | -85 | 517 | -1,380 |
| Other Working Capital | -10,078 | -3,540 | -199 | -4,397 | -3,535 |
| Other Operating Activity | 28,320 | 5,284 | -2,660 | -4,904 | -7,239 |
| Operating Cash Flow | $41,802 | $27,383 | $17,694 | $3,612 | $38,918 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -71 | -107 | -81 | -61 | -56 |
| Purchase Of Investment | -108,141 | -61,204 | -34,420 | -12,507 | -76,230 |
| Sale Of Investment | 72,024 | 52,100 | 24,784 | 14,099 | 55,848 |
| Investing Cash Flow | $-36,188 | $-9,211 | $-9,717 | $1,531 | $-20,438 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -44,440 | -33,330 | -22,220 | -11,110 | -33,330 |
| Common Stock Issued | 130 | 130 | 130 | N/A | 150 |
| Other Financing Activity | -888 | -666 | -444 | -222 | -666 |
| Financing Cash Flow | $-45,198 | $-33,866 | $-22,534 | $-11,332 | $-33,846 |
| Beginning Cash Position | 71,310 | 71,310 | 71,310 | 71,310 | 86,676 |
| End Cash Position | 31,726 | 55,616 | 56,753 | 65,121 | 71,310 |
| Net Cash Flow | $-39,584 | $-15,694 | $-14,557 | $-6,189 | $-15,366 |
| Free Cash Flow | |||||
| Operating Cash Flow | 41,802 | 27,383 | 17,694 | 3,612 | 38,918 |
| Capital Expenditure | -71 | -107 | -81 | -61 | -56 |
| Free Cash Flow | 41,731 | 27,276 | 17,613 | 3,551 | 38,862 |